Acquisition Completed

XenoTherapeutics acquisition of Repare Therapeutics

US$2.20 cash per share

Advisers

Target
Repare Therapeutics
Acquirer
XenoTherapeutics
Target based in
Canada
Buyer based in
United States (unverified)
Completed
28 Jan 2026
Sector
Biotech
Tags
Biotech, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.